The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 29, 2021
Filed:
Aug. 25, 2014
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Ali Amjad, Edison, NJ (US);
Gioconda V. Gallo, Berkely Heights, NJ (US);
Timothy J. Henderson, Natick, MA (US);
Rongze Kuang, Green Brook, NJ (US);
Yeon-hee Lim, Piscataway, NJ (US);
Michael Man-chu Lo, Rahway, NJ (US);
Edward Metzger, Laurel, MD (US);
Manuel DE Lera Ruiz, Perkasie, PA (US);
Andrew Stamford, Morristown, NJ (US);
Paul Tempest, Shanghai, CN;
Brent Whitehead, Morristown, NJ (US);
Heping Wu, Rahway, NJ (US);
Ali Amjad, Edison, NJ (US);
Gioconda V. Gallo, Berkely Heights, NJ (US);
Timothy J. Henderson, Natick, MA (US);
Rongze Kuang, Green Brook, NJ (US);
Yeon-Hee Lim, Piscataway, NJ (US);
Michael Man-Chu Lo, Rahway, NJ (US);
Edward Metzger, Laurel, MD (US);
Manuel de Lera Ruiz, Perkasie, PA (US);
Andrew Stamford, Morristown, NJ (US);
Paul Tempest, Shanghai, CN;
Brent Whitehead, Morristown, NJ (US);
Heping Wu, Rahway, NJ (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
The present invention is directed to 2,2-difluorodioxolo compounds that are antagonists of Areceptor. The present invention is also directed to uses of the 2,2-difluorodioxolo compounds described herein in the potential treatment or prevention of neurological disorders and diseases in which Areceptor are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds and to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which Areceptors are involved.